510(k) device
Rezum System
Nxthera, Inc. · Unit, Electrosurgical, Endoscopic (With Or Without Accessories) (KNS, Class II) · First FDA decision Aug 27, 2015, newest Feb 27, 2018Enlarged prostate (BPH)Pancreatic and bile duct disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
21
Naming "Rezum"
MAUDE reports
1,544
Brand "Rezum", since 2015
PubMed studies
348
Mentioning "Rezum"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Rezum System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Rezum System510(k)
K180237 · Decided Feb 27, 2018 · 29 days after receipt
Device type: Unit, Electrosurgical, Endoscopic (With Or Without Accessories) (KNS) · GI, Urology & Nephrology
- Rezum System510(k)
K160417 · Decided Mar 17, 2016 · 30 days after receipt
Device type: Unit, Electrosurgical, Endoscopic (With Or Without Accessories) (KNS) · GI, Urology & Nephrology
- Rezum System510(k)
K150786 · Decided Aug 27, 2015 · 155 days after receipt
Device type: Unit, Electrosurgical, Endoscopic (With Or Without Accessories) (KNS) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Rezum", any status and sponsor, newest update first.
- Comparing Water Vapour Thermal Therapy (Rezūm) and TURPPivotal-lookingCompleted
Chinese University of Hong KongAcademic, hospital or other
NCT05762198 · 108 participants · Start May 1, 2023 · Primary completion Jun 30, 2026
Device: Rezūm; TURP · For: Benign Prostatic Hyperplasia
Sites: Hong Kong, Hong Kong
Chinese PLA General HospitalAcademic, hospital or other
NCT06817733 · 30 participants (planned) · Start Apr 15, 2025 · Primary completion Dec 30, 2026
Device: Rezūm Water Vapor Thermal Therapy System with MRI/TRUS Fusion and Electromagnetic Navigation · For: Benign Prostatic Hyperplasia (BPH)
Sites: Beijing, China
- Comparing Rezum and UroliftPivotal-lookingRecruiting
Chinese University of Hong KongAcademic, hospital or other
NCT06820606 · 120 participants (planned) · Start Jan 1, 2025 · Primary completion Sep 30, 2027
Device: Rezum; UroLift · For: Benign Prostatic Hyperplasia
Sites: Hong Kong, Hong Kong
18 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Rezum", and for the whole product code for context.
This brand
1,544 reports: 443 malfunction, 1,086 injury, 14 death
Whole product code KNS
10,605 reports: 7,586 malfunction, 2,954 injury, 60 death
Newest reports for this brand
- RezumMalfunction
2124215-2026-57499 · Received Oct 29, 2026 · Event dated Oct 21, 2026
Device type: Unit, Electrosurgical, Endoscopic (With Or Without Accessories) (KNS)
Device problem as coded: Retraction Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- RezumMalfunction
2124215-2026-57500 · Received Oct 29, 2026 · Event dated Oct 22, 2026
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI)
Device problem as coded: Power Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- RezumMalfunction
2124215-2026-57501 · Received Oct 29, 2026 · Event dated Oct 8, 2026
Device type: Unit, Electrosurgical, Endoscopic (With Or Without Accessories) (KNS)
Device problem as coded: Retraction Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0262-2018 · Started Jul 28, 2017
Reason given: Needle Bond may not be able to withstand the tension force applied when the shaped needle is deployed into and retracted from prostate tissue to deliver treatments.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Unit, Electrosurgical, Endoscopic (With Or Without Accessories) (KNS)
Published research
The most relevant PubMed records for "Rezum"[tiab]. The summary above synthesizes these.
- What's New in Rezūm?
Pathak P, Helo S, McVary KT · Eur Urol Focus · 2018Review
- Two-year follow-up comparing Rezūm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study.
Samir M, Elaal AAA, Gad KAS, et al. · Int J Urol · 2024Randomized Controlled Trial, Comparative Study
- Rezūm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled Study.
McVary KT, Rogers T, Roehrborn CG · Urology · 2019Multicenter Study, Randomized Controlled Trial
- Validity of the Rezum Simulator for Trainees.
Alsowayan OS, Al Zahrani AM · Acta Inform Med · 2023
- Office-Based Procedures for BPH.
Gao B, Lu S, Bhojani N, et al. · Curr Urol Rep · 2021Review
- Is less indeed more for Rezum water vapour treatment of the lateral prostate lobes?
Hindley R · BJU Int · 2023Editorial
- Rezum Outcomes in Relationship to Number of Injections: Is Less More?
Babar M, Loloi J, Azhar U, et al. · J Endourol · 2023
- Rezūm water vapor therapy for the treatment of patients with urinary retention and permanent catheter dependence secondary to benign prostate hyperplasia: a systematic review of the literature.
Spinos T, Katafigiotis I, Leotsakos I, et al. · World J Urol · 2023Systematic Review
- What Is New with Rezūm Water Vapor Thermal Therapy for LUTS/BPH?
Doppalapudi SK, Gupta N · Curr Urol Rep · 2021Review
- Rezūm water vapor therapy for catheter-dependent urinary retention: a real-world Canadian experience.
Elterman DS, Bhojani N, Vannabouathong C, et al. · Can J Urol · 2022
- Rezŭm water vaporization therapy versus transurethral resection of the prostate in the management of refractory urine retention: matched pair comparative multicenter experience.
Tayeb W, Azhar RA, Subahi M, et al. · World J Urol · 2024Multicenter Study
- UroLift, Rezūm, and iTind for Benign Prostatic Hyperplasia.
Cheema AS, Long BG, Moore KE, et al. · Urol Clin North Am · 2025Review
Other devices of this type
Also filed under product code KNS.
- Single Use Electrosurgical Knife (KD-612L, KD-612U)Olympus Medical Systems Corporation · 510(k) 2025
- Aqua Medical RF Vapor Ablation SystemAqua Medical, Inc. · 510(k) 2025
- Rezum SystemBoston Scientific · 510(k) 2026
- Single Use Preloaded Sphincterotome V (Distal Wire Guided) (KD-VC600 Series)Olympus Medical Systems Corp. · 510(k) 2025
- Teslatome Bipolar SphincterotomeWilson-Cook Medical, Inc. · 510(k) 2025
- ELRA Electrode (7-2B11SStarmed Co., Ltd. · 510(k) 2023
- SphincterotomeHangzhou AGS MedTech Co., Ltd. · 510(k) 2023
- Rezum SystemNxthera (A Boston Scientific Company) · 510(k) 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.